论文部分内容阅读
为评价肝移植和抗病毒等新疗法的适应症,作者对HBsAg阳性的肝硬变患者进行了较长时间的随访研究。
To assess indications for new therapies such as liver transplantation and antiviral therapy, the authors conducted a long-term follow-up study of HBsAg-positive patients with cirrhosis.